Amedisys, Inc. (NasdaqGS: AMED) Loss Submission Form

Kuznicki Law is investigating the proposed sale of Amedisys, Inc. (NasdaqGS: AMED) to Option Care Health, Inc. (“Option Care”) (NasdaqGS: OPCH).  Under the terms of the proposed transaction, shareholders of Amedisys will receive 3.0213 shares of Option Care for each share of Amedisys that they own. Kuznicki Law is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.